Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

CNTA holding history

Centessa Pharmaceuticals plc in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CNTA overviewAll 13F holders of CNTAFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q3 2021
Holdings of CNTA by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−4,268,353−100.0%Sold outHolders
Q1 20264,268,353$169.5M<0.1%+3,159,255+284.8%AddedHolders
Q4 20251,109,098$27.7M<0.1%−15,347−1.4%ReducedHolders
Q3 20251,124,445$27.3M<0.1%−669,026−37.3%ReducedHolders
Q2 20251,793,471$23.6M<0.1%−1,143,996−38.9%ReducedHolders
Q1 20252,937,467$42.2M<0.1%+1,012,958+52.6%AddedHolders
Q4 20241,924,509$32.2M<0.1%+544,858+39.5%AddedHolders
Q3 20241,379,651$22.1M<0.1%−670,741−32.7%ReducedHolders
Q2 20242,050,392$18.5M<0.1%−86,973−4.1%ReducedHolders
Q1 20242,137,365$24.2M<0.1%+923,315+76.1%AddedHolders
Q4 20231,214,050$9.66M<0.1%+256,099+26.7%AddedHolders
Q3 2023957,951$6.20M<0.1%+133,322+16.2%AddedHolders
Q2 2023824,629$5.10M<0.1%+80,722+10.9%AddedHolders
Q1 2023743,907$2.86M<0.1%+428,772+136.1%AddedHolders
Q4 2022315,135$976.9K<0.1%+298,641+1,810.6%AddedHolders
Q3 202216,494$67.0K<0.1%−23,770−59.0%ReducedHolders
Q2 202240,264$196.0K<0.1%+18,652+86.3%AddedHolders
Q1 202221,612$194.0K<0.1%+7,527+53.4%AddedHolders
Q4 202114,085$158.0K<0.1%+6,455+84.6%AddedHolders
Q3 20217,630$128.0K<0.1%+7,630NewHolders